TITAN PHARMACEUTICALS INC — Director's Dealing 2014

Feb 14, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TITAN PHARMACEUTICALS INC (TTNP.OB)
CIK: 0000910267
Period of Report: 2014-02-12

Reporting Person: BHONSLE SUNIL (Director, President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-02-12	Common Stock	A	100000	$0.66	Acquired	215500	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	300757	Indirect

Footnotes

F1: 25,000 restricted shares vested on the grant date and the balance vest on the first anniversary of the grant date.

F2: The reporting person is the trustee of the family trust owning the indicated shares.

F3: Does not include 10,000 shares held by his adult son.